益气解毒方基于线粒体保护的抗缺血性脑卒中研究(4)
[4]Sachdev PS，Brodaty H，Valenzuela MJ，et al.The neuropsychological profile of vascular cognitive impairment in stroke and TIA patients[J].Neurology，2004，62(6)：912-919.
[5]Samsa GP，Matchar DB.How strong is the relationship between functional status and quality of life among persons with stroke？[J].J Rehabil Res Dev，2004，41(3A)：279-282.
[6]Streifler JY，Eliasziw M，Benavente OR，et al. Prognostic importance of leukoaraiosis in patients with symptomatic internal carotid artery stenosis[J].Stroke，2002，33(6)：1651-1655.
[7]Feigin VL，Forouzanfar MH，Krishnamurthi R，et al.Global and regional burden of stroke during 1990-2010：findings from the Global Burden of Disease Study 2010[J].Lancet，2014，383(9913)：245-254.
[8]Hankey G J.Stroke[J].Lancet，2016，389(10069)：641-654.
[9]Hafez S，Coucha M，Bruno A，et al.Hyperglycemia，acute ischemic stroke，and thrombolytic therapy[J].Transl Stroke Res，2014，5(4)：442-453.
[10]Zhao L，Peng F，Guan B，et al.Whether Metal Element-Containing Herbal Formula Angong Niuhuang Pill Is Safe for Acute Brain Disorders？[J].Biol Trace Elem Res，2015，166(1)：41-48.
[11]Zhu XL，Xiong LZ，Wang Q，et al.Therapeutic time window and mechanism of tetramethylpyrazine on transient focal cerebral ischemia/reperfusion injury in rats[J].Neurosci Lett，2009，449(1)：24-27.
[12]Longa EZ，Weinstein PR，Carlson S， et al. Reversible middle cerebral artery occlusion without craniectomy in rats[J].Stroke，1989，20(1)：84-91.
[13]Ballabh P，Braun A，Nedergaard M.The blood-brain barrier： an overview：structure，regulation，and clinical implications[J].Neurobiol Dis，2004，16(1)：1-13.
[14]Xia T，Jiang C，Li L，et al.A study on permeability transition pore opening and cytochrome c release from mitochondria， induced by caspase-3 in vitro[J].FEBS Lett，2002，510(1-2)：62-66.
[15]朱麗，高健，吴传鸿，等.益气解毒方对大鼠局灶性脑缺血氧化应激的影响[J].中国实验方剂学杂志，2013，19(6)：171-173., 百拇医药(杨若聪 田朋朋 吴传鸿 段飞鹏 陈修平 张丽红 闫智勇 李韶菁)
[5]Samsa GP，Matchar DB.How strong is the relationship between functional status and quality of life among persons with stroke？[J].J Rehabil Res Dev，2004，41(3A)：279-282.
[6]Streifler JY，Eliasziw M，Benavente OR，et al. Prognostic importance of leukoaraiosis in patients with symptomatic internal carotid artery stenosis[J].Stroke，2002，33(6)：1651-1655.
[7]Feigin VL，Forouzanfar MH，Krishnamurthi R，et al.Global and regional burden of stroke during 1990-2010：findings from the Global Burden of Disease Study 2010[J].Lancet，2014，383(9913)：245-254.
[8]Hankey G J.Stroke[J].Lancet，2016，389(10069)：641-654.
[9]Hafez S，Coucha M，Bruno A，et al.Hyperglycemia，acute ischemic stroke，and thrombolytic therapy[J].Transl Stroke Res，2014，5(4)：442-453.
[10]Zhao L，Peng F，Guan B，et al.Whether Metal Element-Containing Herbal Formula Angong Niuhuang Pill Is Safe for Acute Brain Disorders？[J].Biol Trace Elem Res，2015，166(1)：41-48.
[11]Zhu XL，Xiong LZ，Wang Q，et al.Therapeutic time window and mechanism of tetramethylpyrazine on transient focal cerebral ischemia/reperfusion injury in rats[J].Neurosci Lett，2009，449(1)：24-27.
[12]Longa EZ，Weinstein PR，Carlson S， et al. Reversible middle cerebral artery occlusion without craniectomy in rats[J].Stroke，1989，20(1)：84-91.
[13]Ballabh P，Braun A，Nedergaard M.The blood-brain barrier： an overview：structure，regulation，and clinical implications[J].Neurobiol Dis，2004，16(1)：1-13.
[14]Xia T，Jiang C，Li L，et al.A study on permeability transition pore opening and cytochrome c release from mitochondria， induced by caspase-3 in vitro[J].FEBS Lett，2002，510(1-2)：62-66.
[15]朱麗，高健，吴传鸿，等.益气解毒方对大鼠局灶性脑缺血氧化应激的影响[J].中国实验方剂学杂志，2013，19(6)：171-173., 百拇医药(杨若聪 田朋朋 吴传鸿 段飞鹏 陈修平 张丽红 闫智勇 李韶菁)